
EXOZ
Healthcare · Biotechnology · $35.6M market cap
$3.83-0.17 (-4.3%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | — | — | — |
| Aug 13, 2026 | Time not confirmed | — | -0.33 | — |
| Nov 13, 2025 | Time not confirmed | — | -0.27 | — |
| Aug 12, 2025 | Time not confirmed | — | -0.28 | — |
| May 12, 2025 | Time not confirmed | — | -0.22 | — |
| Mar 31, 2025 | Time not confirmed | — | -0.24 | — |
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.